Wed, March 24, 2021
Tue, March 23, 2021
Mon, March 22, 2021

Mani Foroohar Maintained (BBIO) at Buy with Increased Target to $75 on, Mar 23rd, 2021

Mani Foroohar of SVB Leerink, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $67 to $75 on, Mar 23rd, 2021.

Mani has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Mani


  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $86 on, Thursday, March 4th, 2021
  • Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $83 on, Tuesday, February 9th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $87 on, Monday, January 11th, 2021